yohimbine has been researched along with sq-11725 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Berlan, M; Galitzky, J; Montastruc, P; Tran, MA | 1 |
Bagheri, H; Berlan, M; Chale, JJ; Guyen, LN; Montastruc, JL; Tran, MA | 1 |
Brabant, G; Drube, J; Helfritz, F; Nave, H; Pabst, R; von Hörsten, S | 1 |
Härle, P; Janele, D; Pongratz, G; Schnellinger, G; Schölmerich, J; Straub, RH | 1 |
6 other study(ies) available for yohimbine and sq-11725
Article | Year |
---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Anorectic effect of alpha 2-antagonists in dog: effect of acute and chronic treatment.
Topics: Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Blood Glucose; Blood Platelets; Body Weight; Catecholamines; Cell Membrane; Dioxanes; Dogs; Fatty Acids, Nonesterified; Feeding Behavior; Idazoxan; Imidazoles; Insulin; Male; Nadolol; Yohimbine | 1991 |
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Autonomic Pathways; Dogs; Female; Insulin; Lipids; Male; Muscarinic Antagonists; Nadolol; Norepinephrine; Parasympathetic Nervous System; Salivation; Sympathetic Nervous System; Yohimbine | 1995 |
Leukocyte mobilization induced by hypervolemia is due to a combined alpha- and beta-adrenoceptor activation.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Leukocyte Count; Leukocytes; Male; Nadolol; Norepinephrine; Rats; Rats, Inbred Lew; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sodium Chloride; Specific Pathogen-Free Organisms; Stress, Physiological; Yohimbine | 2000 |
Norepinephrine in mice inhibits secretion of splenic IL-6 during the dark period but stimulates its secretion in the light period--possible role of the corticosterone tone.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Corticosterone; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hormone Antagonists; In Vitro Techniques; Interleukin-6; Mice; Mice, Inbred Strains; Mifepristone; Nadolol; Norepinephrine; Perfusion; Phentolamine; Photoperiod; Spleen; Statistics, Nonparametric; Time Factors; Yohimbine | 2005 |